Clinical Trial Update: Mepolizumab to CRSwNP Through 12 Months - Randomised to FESS and Non-FESS Within the First 2 Weeks [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for mepolizumab in chronic rhinosinusitis with nasal polyps (CRSwNP), comparing outcomes through 12 months in patients randomize…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: Vibeke Backer | Conditions: Chronic Rhinosinusitis with Nasal Polyps, Asthma | Phase 4 | Status: ACTIVE_NOT_RECRUITING